Background. Campylobacter is a leading cause of foodborne illness in the United States. Understanding laboratory practices is essential to interpreting incidence and trends in reported campylobacteriosis over time and provides a baseline for evaluating the increasing use of culture-independent diagnostic methods for Campylobacter infection.
FoodNet sites in 2009 were approximately 30% lower than those during baseline years of 1996-1998. However, most of the decrease occurred before 2004 [5] .
Attributing trends in laboratory-confirmed Campylobacter infection to decreases in infection rates presupposes that clinical laboratory practices remain stable. Current clinical laboratory practices for Campylobacter testing appear to be changing with the increasing availability of new cultureindependent stand-alone tests for direct detection of Campylobacter from stool specimens. As the current FoodNet case definition of campylobacteriosis requires culture confirmation, it is critical to understand not only these changing laboratory practices, but also the performance characteristics of existing laboratory methods in order to assure the validity of public health surveillance data. Campylobacters are fastidious organisms that require microaerobic conditions for growth, so methods used for stool specimen collection, transport, and culture can have a large effect on sensitivity of testing. Despite the availability of guidelines for the collection, transport, and isolation of Campylobacter from human fecal specimens [6] , actual procedures used by clinical laboratories may vary. Surveys of clinical laboratories in FoodNet sites in 1995, 1998, and 2000 indicated that stool specimens are universally tested for Campylobacter species during routine enteric testing [7] . However, these surveys did not address the actual laboratory techniques and methods used.
In 2005, FoodNet conducted a survey of clinical laboratories to describe routine practices used for the isolation and identification of Campylobacter. Since the survey was conducted, culture-independent diagnostic methods, which are thought to be generally more sensitive but less specific than culture-based methods, have become commercially available and evaluation of these new rapid stool antigen tests has begun [8, 9] . Describing culture-based practices is important, both as a baseline against which to assess the impact of newer methods on disease surveillance and to inform considerations of whether, when, and how FoodNet case definitions should be modified to reflect changing diagnostic practices.
METHODS
FoodNet is a collaboration between the Centers for Disease Control and Prevention (CDC), 10 participating state health departments, the US Department of Agriculture's Food Safety and Inspection Service, and the US Food and Drug Administration. Initiated in 1996 as part of the CDC's Emerging Infections Program, FoodNet conducts population-based, active laboratory surveillance for and epidemiologic studies of infections transmitted commonly through food [10, 11] .
To obtain information regarding laboratory characteristics, stool specimen collection, transport methods and times, and culture and incubation procedures used to isolate and identify Campylobacter in 2004, a survey was distributed in 2005 to all laboratories serving the following FoodNet sites participating in the survey: Connecticut, Georgia, Maryland, Minnesota, Oregon, Tennessee, and selected counties in California, Colorado, and New York. Lead laboratory microbiologists were mailed a letter describing the study, the survey instrument, a 1-page summary of FoodNet surveillance data, and a previous publication of FoodNet laboratory survey results [7] . FoodNet staff in each site contacted the laboratories that did not respond to encourage completion and return of the survey.
To assess a given laboratory's overall testing algorithm for isolating Campylobacter from stool specimens, a laboratory testing profile was assigned to participating laboratories based on their responses to questions in the survey regarding practices that could affect a laboratory's ability to recover and isolate Campylobacter from stool specimens. The questions from the survey used to determine the laboratory testing profiles are highlighted in Tables 1 and 2 . Descriptive statistics were calculated using SAS software, version 9.1 (SAS Institute, Cary, North Carolina). Throughout the study, percentages were based on the number of laboratories responding to each individual question.
RESULTS
The survey was mailed to 583 laboratories; 534 (92%) responded. Most (86%) laboratories were hospital-based (n 5 460). Other types of laboratories included government (n 5 24), community/reference (n 5 22), and clinic-based (n 5 15); 13 were other or unidentified types. Of those laboratories receiving any stool specimens for testing for enteric bacterial pathogens, microbial toxins, ova and parasites, or viruses, 97% (n 5 423) reported conducting on-site testing for enteric bacterial pathogens; of these, 97% (n 5 411) reported testing for Campylobacter on-site, and 90% (n 5 370) did so routinely. Only responses from those 411 laboratories reporting on-site testing for Campylobacter were included in further analysis.
Overall, specimens (whole stools and/or rectal swabs) were received in transport medium by 97% (336) of 345 laboratories. Of the laboratories reporting receipt of any whole stool specimens, 96% received $75% of their specimens as whole stools as opposed to rectal swabs; of those laboratories that described transport of whole stools, 83% reported receiving the specimens in transport medium. Of the laboratories that received any rectal swabs, only 2% received $75% of their specimens as swabs; 1 laboratory reported receiving only rectal swabs. Of those laboratories that described transport of rectal swabs, 87% reported receiving the specimens with transport medium. The transport medium of choice overall was Cary-Blair (243 of 294 laboratories [83%]) ( Table 1 ). The mean transit time from the medical practitioner to the laboratory was #2 hours for 46% (165) of 356 laboratories that responded; 19% reported a mean time of .8 hours (range, ,1-96 hours). Among laboratories with transit times of .2 hours, 91% reported use of transport medium. Seventynine percent (305) of 386 laboratories indicated that they rejected specimens received without transport medium. Immediate processing of specimens was reported more often when specimens were received without transport medium (142 of 394 laboratories [36%]) than when specimens were received with transport medium (63 of 321 laboratories [20%]). However, 32% of laboratories reported holding any specimens (whole stools or rectal swabs) at room temperature without either refrigeration or transport medium (Table 1) .
For Campylobacter infection diagnosis, 97% (396) of 407 laboratories used only culture, 2.5% of laboratories used both culture and culture-independent methods, and 1 laboratory used a culture-independent method only. Only 5% (21) of 411 laboratories used enrichment broth, and only 1% (5) of 404 laboratories used a filtration method when processing the stool specimen. Ninety-seven percent (397) of 411 laboratories reported using selective medium to isolate Campylobacter from stool specimens; Campy blood agar plate (52% of laboratories) and Campy cefoperazone, vancomycin, and amphotercin agar (CVA; 38% of laboratories) were the selective media most commonly used. The nonselective media Tryptic soy agar (38% of laboratories) and blood agar base (52% of laboratories) were used in conjunction with a selective medium by 54 of 56 (96%) laboratories. Two laboratories reported using only nonselective medium for isolation of Campylobacter. Eleven laboratories reported using .1 type of medium during 2004, but they did not specify whether the media were used concurrently or whether the medium they were using changed during the course of 2004 (Table 2) . ) reported creating the recommended microaerobic environment of approximately 5% oxygen, 10% carbon dioxide, and 85% nitrogen immediately after plating. Commercial gas packs were used by 88% (351) of 400 laboratories, and 9% of the laboratories reported using an evacuation and replacement gas mixture method. Holding or batching plates before generating the recommended microaerobic environment was reported by 14% (49) of 354 respondents (Table 2) . Among those laboratories that identified isolates to the species level (124 of 403 [31%] ), the most common phenotypic method used was hippurate hydrolysis (76% of laboratories); 2% reported using species-specific polymerase chain reaction (PCR) for speciation. Antimicrobial sensitivity testing was performed at 4% of the laboratories. Less than one-half (168 [44%]) of 386 laboratories reported that they forwarded Campylobacter isolates to state public health laboratories. Thirteen percent (52 of 402 laboratories) indicated having made changes to their Campylobacter isolation practices since 2000, including changes in methods for speciation; changes in times for holding plates before reporting results as negative; and changes to transport medium, culture medium, or methods used to create microaerobic conditions.
A complete laboratory testing profile was generated for 52% (214) of the 411 laboratories that reported on-site testing for Campylobacter and that reported complete information needed for profiling. Among these 214 laboratories, 106 different laboratory testing profiles were identified. Only 7% (16) of 214 laboratories were fully compliant with existing guidelines available in the Manual of Clinical Microbiology [6] . Among all laboratories, the most common deviations were as follows: (1) not using transport medium for specimens with a .2-hour delay in transport; (2) holding specimens received in transport medium at room temperature rather than processing immediately or storing specimens at 4°C; (3) using Campy blood agar plate selective medium; (4) batching plates and holding them at room temperature before placing them in a microaerobic atmosphere; (5) using candle jars to generate reduced oxygen growth conditions; and (6) incubating plates for 48 hours instead of 72 hours before reporting results as negative. When the 214 laboratories with complete testing profiles were combined with the 163 laboratories that had incomplete testing profiles but that had answered the survey questions related to the 6 testing deviations described above, 33% (125) of 377 laboratories had 1 deviation, 39% (147) had 2 deviations, and 24% (89) had $3 deviations from the existing guidelines.
DISCUSSION
At the time of this survey, many laboratories in the FoodNet catchment area were using laboratory practices that were likely to reduce the sensitivity of isolation of Campylobacter from stool specimens. Although we cannot quantify the impact of this variation on the measured incidence of Campylobacter infection, it is likely that it has led to some degree of underdiagnosis. This survey had a high response rate (.90%), indicating that the results presented in this report reliably reflect the laboratory practices of clinical laboratories serving FoodNet sites.
Adherence to the latest available guidelines [12] is essential to maximize the recovery of Campylobacter from clinical specimens. Campylobacter has extremely fastidious growth requirements and is susceptible to environmental stresses (eg, exposure to air, freezing, and drying) that can affect its survival and subsequent recovery [13] . Guidelines for the collection, transport, and isolation of Campylobacter from human fecal specimens that were available at the time of the surveys [6] called for the following: the use of a transport medium, such as Cary-Blair, for all rectal swabs and for all specimens when a delay of $2 hours until plating is anticipated; specimen storage at 4°C if the specimen is not processed immediately; culture on $1 selective medium (eg, Campy CVA, CCDA [cefoperazone charcoal deoxycholate agar], or CSM [charcoal selective medium]); incubation at 42°C for at least 72 hours; and immediate placement of medium in a microaerobic atmosphere once a specimen is plated. Our survey identified wide variation in laboratory practice and little compliance with existing guidance; only 7% of laboratories were fully adherent, and 63% of laboratories had $2 deviations from existing recommendations. These results, as well as those of other surveys [7, 14, 15] , highlight a clear need for standardized best practice recommendations for the detection and isolation of Campylobacter from stool specimens.
A shift in testing practices has implications both for patient management and public health surveillance. With stable diagnostic practices, trends in incidence of infection can be discerned even with substantial underdiagnosis. However, when diagnostic practices change in ways that may affect the sensitivity and specificity of the surveillance system, the ability to discern trends can be compromised. At the time this survey was completed, only 1 laboratory surveyed in the FoodNet catchment area reported using a culture-independent method as a stand-alone test for the detection of Campylobacter in stool specimens. Since then, more choices for cultureindependent testing for Campylobacter have become commercially available, and the use of culture-independent methods for the direct detection of Campylobacter from stool specimens appears to be increasing in FoodNet sites (CDC, unpublished data, 2010). To the extent that these tests come into common use, interpretation of reported incidence of Campylobacter infection may be complicated. On the one hand, the current FoodNet case definition of campylobacteriosis requires culture confirmation; cases diagnosed only by cultureindependent testing do not meet the case definition. This would tend to lower the measured incidence. On the other hand, if the case definition were expanded to include cases diagnosed with reportedly more sensitive and less specific tests, then the measured incidence would tend to increase as additional true-and false-positive cases were counted.
A growing number of studies are beginning to evaluate culture-independent assays; 2 such studies report these new Campylobacter infection diagnostic tests to provide a rapid and reliable alternative to culture-based testing [8, 9] , and another prospective multicenter study to evaluate the real-world performance of stool antigen immunoassays in comparison with culture and PCR for detection of Campylobacter in stool specimens is in progress [16] . However, at this time, no recommendations have been developed for the transport or isolation of the organism from stool immunoassay positive broths. Our survey revealed that most clinical laboratories do not routinely forward Campylobacter specimens to their state public health laboratories. In addition, no guidelines exist for interpreting and reporting discordant results between culture and culture-independent results for a given specimen. Unlike culture-independent testing for Shiga toxin-producing Escherichia coli, for which laboratory recommendations have been published [17] , no formal guidance is currently available regarding the use of culture-independent testing methods for the direct diagnosis of Campylobacter infection from stool specimens; a collaborative partnership between clinical and public health partners to develop best practices recommendations for Campylobacter infection diagnostic testing will begin soon and is urgently needed.
The information obtained through this survey can be used as a baseline for the evaluation of Campylobacter-related laboratory practices in future surveys. The lack of adherence to the currently available guidelines, as shown by this survey, underscores the urgent need for standardized and more formal best practice recommendations to address laboratory practices, with both culture and culture-independent testing methods, for the detection and isolation of Campylobacter from stool specimens. Our data, in conjunction with FoodNet surveillance data currently being collected to monitor testing practices in clinical laboratories, as well as data collected to evaluate the performance of culture-independent assays and commercially available Campylobacter selective medium, can inform the development of best practice recommendations for Campylobacter infection diagnostic testing to be used by clinical and public health laboratories.
